During a period of ten years (1987-1996) in Iaşi Infections Diseases Hospital, were observed 19 children, 0-1 year, with pneumococcal meningitis. This disease represented one important cause of morbidity and mortality in children in developing countries. Clinical symptoms in these cases were very serious, including: fever, headache, vomiting, altered sensorium, seizures etc. Cerebrospinal fluid analysis confirmed the diagnosis, after showing purulent, turbid fluid. The germ was isolated in 100% of the cases through direct examination and culture of cerebrospinal fluid. They were treated with penicillin and chloramphenicol (55%) and ampicillin and chloramphenicol. The mortality was 52%. This study concludes that delay in diagnosis, virulence of germ, prematurity and hypertrophy were elements of a bad prognosis.

Download full-text PDF

Source

Publication Analysis

Top Keywords

pneumococcal meningitis
8
cerebrospinal fluid
8
retrospective clinical
4
clinical study
4
study pneumococcal
4
meningitis 1-year-old
4
1-year-old infants
4
infants hospitalized
4
hospitalized 1987-1996
4
1987-1996 infectious
4

Similar Publications

Background: Pneumococcal conjugate vaccines (PCVs) introduced in childhood national immunization programs lowered vaccine-type invasive pneumococcal disease (IPD), but replacement with non-vaccine-types persisted throughout the PCV10/13 follow-up period. We assessed PCV10/13 impact on pneumococcal meningitis incidence globally.

Methods: The number of cases with serotyped pneumococci detected in cerebrospinal fluid and population denominators were obtained from surveillance sites globally.

View Article and Find Full Text PDF

Background: Purulent meningitis poses a significant clinical challenge with high mortality. We present the case of a 54-year-old female transferred to our emergency department with suspected bacterial meningitis, later diagnosed as an Austrian syndrome.

Case Presentation: The patient exhibited subacute somnolence, severe headache, nausea and fever.

View Article and Find Full Text PDF

Development of a broad-spectrum epitope-based vaccine against Streptococcus pneumoniae.

PLoS One

January 2025

Bangladesh Council of Scientific and Industrial Research (BCSIR), Dhaka, Bangladesh.

Streptococcus pneumoniae (SPN) is a significant pathogen causing pneumonia and meningitis, particularly in vulnerable populations like children and the elderly. Available pneumonia vaccines have limitations since they only cover particular serotypes and have high production costs. The emergence of antibiotic-resistant SPN strains further underscores the need for a new, cost-effective, broad-spectrum vaccine.

View Article and Find Full Text PDF

Determinants of cerebrospinal fluid leakage in a large cohort of macroprolactinomas.

Ann Endocrinol (Paris)

January 2025

Assistance publique-Hôpitaux de Paris, Pituitary Unit, Pitié-Salpêtrière Hospital, 75013 Paris, France. Electronic address:

Introduction: Macroprolactinomas are the most frequent subtype of pituitary adenomas. Their treatment has been improved since the onset of dopamin agonists (DA). Nevertheless, DA can cause a cerebospinal fluid (CSF) leakage by shrinking the tumor and lead to a bacterial meningitis.

View Article and Find Full Text PDF

Background: Streptococcus pneumoniae is an important cause of pneumonia, sepsis, and meningitis, which are leading causes of child mortality. Pneumococcal conjugate vaccines (PCVs) protect against disease and nasopharyngeal colonization with vaccine serotypes, reducing transmission to and among unvaccinated individuals. Mozambique introduced 10-valent PCV (PCV10) in 2013.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!